Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway. [electronic resource]
Producer: 20180220Description: 10145-10160 p. digitalISSN:- 1949-2553
- Active Transport, Cell Nucleus
- Adaptor Proteins, Signal Transducing -- genetics
- Angiomotins
- Animals
- Antineoplastic Agents -- pharmacology
- Bone Morphogenetic Protein 4 -- genetics
- Bone Morphogenetic Protein Receptors -- antagonists & inhibitors
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation -- drug effects
- Dose-Response Relationship, Drug
- Gene Expression Regulation, Neoplastic
- Hippo Signaling Pathway
- Humans
- Intercellular Signaling Peptides and Proteins -- genetics
- Male
- Membrane Proteins -- genetics
- Mice, SCID
- Microfilament Proteins
- Phosphoproteins -- genetics
- Prostatic Neoplasms -- drug therapy
- Protein Serine-Threonine Kinases -- metabolism
- Pyrazoles -- pharmacology
- Pyrimidines -- pharmacology
- RNA Interference
- Signal Transduction -- drug effects
- Time Factors
- Transcription Factors
- Transfection
- YAP-Signaling Proteins
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.